目的:分析盐酸特比萘芬片治疗真菌性皮肤病的疗效和安全性。方法:随机将我院2013年10月至2015年8月收治的70例真菌性皮肤病患者分为两组各35例,对照组涂抹适量盐酸特比萘芬软膏,在此基础上观察组口服盐酸特比萘芬片,比较两组患者的临床疗效及不良反应。结果:对照组和观察组患者的总有效率为71.4%和91.4%,对比具有显著性差异(P<0.05);治疗期间,所有患者均未出现严重不良反应。结论:真菌性皮肤病患者服用盐酸特比萘芬片的临床疗效显著,安全性良好,值得临床推广和使用。 Objective: To analyze the efficacy and safety of terbinafine hydrochloride tablets in the treatment of fungal dermatosis. Methods: Seventy patients with fungal dermatosis treated in our hospital from October 2013 to August 2015 were randomly divided into two groups of 35 cases. The control group was treated with terbinafine hydrochloride ointment. On the basis of this, the observation group was given orally Terbinafine hydrochloride tablets, clinical efficacy and adverse reactions in both groups were compared. Results: The total effective rates of the control group and the observation group were 71.4% and 91.4%, respectively, with significant difference (P <0.05). No serious adverse reactions occurred in all the patients during the treatment period. Conclusion: The clinical efficacy of Terbinafine hydrochloride tablets in patients with fungal skin diseases is significant, safe and worthy of clinical promotion and use.